Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ihsuan Tseng
Observed names:
I Hsuan Tseng,
I. Tseng,
Tseng, Ihsuan
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Clinical Research Center
ORCID:
0000-0002-7245-4517
Observed ORCID:
0000-0002-7245-4517
OpenAlex ID:
A5112855176
Epidemiological landscape of esophageal cancer in Asia: Results from GLOBOCAN 2020
2023
·
Hongcheng Zhu
, Zezhou Wang
, et al.
·
Thoracic Cancer
·
65
PDF
Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs
2023
·
Ihsuan Tseng
, Dashan Ai
, et al.
·
Radiation Oncology
·
26
PDF
Radiation Dose–Volume Effects on Negative Tumor-Draining Lymph Nodes Affected T-cell Activation and Prognosis in Esophageal Cancer with Chemoradiotherapy
2025
·
Ihsuan Tseng
, Yun Chen
, et al.
·
Clinical Cancer Research
·
20
Less Irradiation to Lymphocyte-Related Organs Reduced the Risk of G4 Lymphopenia in Esophageal Cancer: Re-Analysis of Prospective Trials
2023
·
Ihsuan Tseng
, Fangfang Li
, et al.
·
The Oncologist
·
16
PDF
Dose escalation based on 18F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12)
2022
·
Hongcheng Zhu
, Qiufang Liu
, et al.
·
Radiation Oncology
·
9
PDF
PD-1 inhibitor improves radiosensitivity by tumor vessel normalization
2025
·
Shengnan Hao
, Dashan Ai
, et al.
·
British Journal of Cancer
·
5
PDF
Immune characteristics and genetic markers of esophageal cancer by single-cell analysis: implications for immunotherapy
2023
·
Bing Xu
, Ihsuan Tseng
, et al.
·
Journal of Thoracic Disease
·
4
PDF
Long-Term Results of a Phase 2 Study of Definitive Chemoradiation Therapy Using S-1 for Esophageal Squamous Cell Carcinoma Patients Who Were Elderly or With Serious Comorbidities
2022
·
Yun Chen
, Zhengfei Zhu
, et al.
·
Frontiers in Oncology
·
4
PDF
Data from Radiation Dose–Volume Effects on Negative Tumor-Draining Lymph Nodes Affected T-cell Activation and Prognosis in Esophageal Cancer with Chemoradiotherapy
2025
·
Ihsuan Tseng
, Yun Chen
, et al.
·
1
P-100 CXCL8 is a valid potential prognostical marker for esophageal squamous cell carcinoma
2022
·
I. Tseng
, B. Xu
, et al.
·
Annals of Oncology
·
1
Supplementary Tables 1 from Radiation Dose–Volume Effects on Negative Tumor-Draining Lymph Nodes Affected T-cell Activation and Prognosis in Esophageal Cancer with Chemoradiotherapy
2025
·
Ihsuan Tseng
, Yun Chen
, et al.
Supplementary Figures 1 from Radiation Dose–Volume Effects on Negative Tumor-Draining Lymph Nodes Affected T-cell Activation and Prognosis in Esophageal Cancer with Chemoradiotherapy
2025
·
Ihsuan Tseng
, Yun Chen
, et al.
Interim position emission tomography-computed tomography during multimodality treatment of locally advanced esophageal cancer: a scoping review
2023
·
Hongcheng Zhu
, Shengnan Hao
, et al.
·
Quantitative Imaging in Medicine and Surgery
PDF
Phase II Study of Definitive Chemoradiation Therapy Using S-1 for Esophageal Squamous Cell Carcinoma Patients --- the ESO-Shanghai 7 Trial Protocol
2020
·
Ihsuan Tseng
, Yun Chen
, et al.
PDF
Show more works
View as search
Works count:
17
Citation count:
151
H-index:
5
I10-index:
4
Year
Topic
Type